ライフサイエンスコーパス: bone marrow stromal cell

1 ers (alginate and hyaluronic acid) and mouse bone marrow stromal cells.

2 5 increases IL-6 expression and secretion in bone marrow stromal cells.

3 decreasing myeloma heterotropic adhesion to bone marrow stromal cells.

4 cell contact with and cytokine production by bone marrow stromal cells.

5 d in advanced disease and in the presence of bone marrow stromal cells.

6 develop drug resistance on interaction with bone marrow stromal cells.

7 cations, as previously demonstrated in human bone marrow stromal cells.

8 rleukin-6, insulin-like growth factor-1, and bone marrow stromal cells.

9 latory activity of the conditioned medium on bone marrow stromal cells.

10 functional mitochondria from murine or human bone marrow stromal cells.

11 l activation of ILK/Akt in both leukemic and bone marrow stromal cells.

12 growth induced by coculture of WM cells with bone marrow stromal cells.

13 or 1 (IGF-1), or by adherence of MM cells to bone marrow stromal cells.

14 ase of mature and immature granulocytes from bone marrow stromal cells.

15 K1-Tr in BCCs, which seems to be reversed by bone marrow stromal cells.

16 P2-induced osteogenic differentiation of ST2 bone marrow stromal cells.

17 rgeting of both leukemic cells and activated bone marrow stromal cells.

18 ating FGF2 inhibition of SDF-1 expression in bone marrow stromal cells.

19 duces SDF-1 secretion and protein content in bone marrow stromal cells.

20 influence the bone-regenerative capacity of bone marrow stromal cells.

21 g hematopoietic precursors on the surface of bone marrow stromal cells.

22 in high glucose media increased adhesion to bone marrow stromal cells.

23 duces apoptosis even of MM cells adherent to bone marrow stromal cells.

24 al peripheral blood mononuclear cells and MM bone marrow stromal cells.

25 teoglycans in modulating bone formation from bone marrow stromal cells.

26 modulating the proliferation and survival of bone marrow stromal cells.

27 uman and the mouse point to a host origin of bone marrow stromal cells.

28 M cell proliferation when MM cells adhere to bone marrow stromal cells.

29 ultures with a CD56(-) cell line or adherent bone marrow stromal cells.

30 n in a paracrine loop involving MM cells and bone marrow stromal cells.

31 , patient MM cells, and MM cells adherent to bone marrow stromal cells.

32 cular endothelial growth factor secretion by bone marrow stromal cells.

33 nal cord lesion site grafted with autologous bone marrow stromal cells.

34 (4) Caprotite grafts seeded with autologous bone marrow stromal cells.

35 reosteoblastic cells and primary cultures of bone marrow stromal cells.

36 nterleukin-6 (IL-6), and IL-11 production by bone marrow stromal cells.

37 enesis by activating Jak2/Stat3 signaling in bone marrow stromal cells.

38 whereas the ligand ephrinB2 is expressed in bone marrow stromal cells.

39 Similar results were obtained in mouse bone marrow stromal cells.

40 icantly stimulated the expression of BMP7 in bone marrow stromal cells.

41 one marrow infiltration and interaction with bone marrow stromal cells.

42 educed tyrosine phosphorylation in CD47(-/-) bone marrow stromal cells.

43 -retinoic acid receptor signaling pathway in bone marrow stromal cells.

44 stly from resistant disease in cocultures of bone marrow stromal cells.

45 +)-enriched primary cells in the presence of bone marrow stromal cells.

46 o different conditions, including cocultured bone marrow stromal cells.

47 ctive effects of cytokines (IL-6, IGF-1) and bone marrow stromal cells.

48 a and MM cell lysis, even in the presence of bone marrow stromal cells.

49 specific for mouse IPC, which recognize the bone marrow stromal cell Ag 2 (BST2).

50 The bone marrow stromal cell Ag 2 (BST2, aka HM1.24, tetheri

51 /- 2%), compared with the transplantation of bone marrow stromal cells alone (23 +/- 3%).

52 scaffolds as cell carriers, we transplanted bone marrow stromal cells alone or with endothelial cell

53 ates bone formation by inducing migration of bone marrow stromal cells, also known as bone mesenchyma

54 Furthermore, their uptake by bone marrow stromal cells altered their secretion of gro

55 FGF2 as an inhibitor of SDF-1 production in bone marrow stromal cells and a regulator of stromal cel

56 the mineralization phenotype of Igfbp2(-/-) bone marrow stromal cells and calvarial osteoblasts.

57 significantly decreased MM cell adhesion to bone marrow stromal cells and collagen I.

58 ancer cells binds to its receptor present on bone marrow stromal cells and favors osteoblastic respon

59 ated significant reduction in adhesion to MM bone marrow stromal cells and fibronectin along with red

60 nation of new bone formation in mineralizing bone marrow stromal cells and HA-TCP transplants.

61 of proliferative/antiapoptotic cytokines or bone marrow stromal cells and has additive or synergisti

62 cts the differentiation defects of Atf4(-/-) bone marrow stromal cells and Ihh-blocking antibody elim

63 decreased the proliferation and survival of bone marrow stromal cells and inhibited the differentiat

64 f this osteogenic ability was performed with bone marrow stromal cells and juvenile calvarial-derived

65 Bone marrow stromal cells and osteoblasts derived from t

66 d osteoblast differentiation and function in bone marrow stromal cells and osteoblasts from DeltaF508

67 TGF-beta directly binds to its receptors on bone marrow stromal cells and overactivates its signalin

68 tor-1 (SDF-1) is constitutively expressed by bone marrow stromal cells and plays key roles in hematop

69 timulates the expression of interleukin-6 in bone marrow stromal cells and provides a novel function

70 2 or IRF4 both decreases MM cell adhesion to bone marrow stromal cells and reduces MM cell homing to

71 of LepR on osteogenesis and adipogenesis by bone marrow stromal cells and systemic effects on bone r

72 increase the expression of interleukin-6 by bone marrow stromal cells and that stimulation does not

73 osteoblast differentiation in primary mouse bone marrow stromal cells and that TRPS1 regulates the e

74 progenitor B lymphocytes (pre-B cells) with bone marrow stromal cells and the model PAH 7,12-dimethy

75 proliferation and apoptosis in macrophages, bone marrow stromal cells and VSMCs cultured from these

76 sing sequential in vitro coculture on murine bone marrow stromal cells, and engraftment into human th

77 oxicity was observed against MM cells versus bone marrow stromal cells, and SN38 inhibited adhesion-i

78 rleukin 6 (IL-6) stimulation, coculture with bone marrow stromal cells, and when harboring a constitu

79 osis was partially blunted by coculture with bone marrow stromal cells antagonizing MEK-ERK dephospho

80 herin, a cell surface protein encoded by the Bone Marrow Stromal Cell Antigen (BST2) known to play an

81 We tested bone marrow stromal cell antigen 2 (BST-2) gene variants

82 SG15), tripartite motif 5alpha (TRIM5alpha), bone marrow stromal cell antigen 2 (BST-2)/tetherin, and

83 nzyme, catalytic polypeptide 3 (APOBEC3) and bone marrow stromal cell antigen 2 (BST-2/tetherin/CD317

84 Bone marrow stromal cell antigen 2 (BST2) is a cellular

85 odulator VPU, reduced steady-state levels of bone marrow stromal cell antigen 2 (BST2; also called CD

86 sed by human cell lines and identified it as bone marrow stromal cell antigen 2 (BST2; CD317).

87 Transcripts for the bone marrow stromal-cell antigen 2 (BST2) gene, encoding

88 Finally, we identified that bone marrow stromal cells are a source of the Shh ligand

89 nt in view of data demonstrating that murine bone marrow stromal cells are also capable of clearing a

90 Although interactions with bone marrow stromal cells are essential for multiple mye

91 Bone marrow stromal cells are known to transiently expre

92 C12 pheochromocytoma cells and primary mouse bone marrow stromal cells as models for growth factor-re

93 st proliferation, leukaemic cell adhesion to bone marrow stromal cells as well as migration of AML bl

94 Finally, although binding of MM cells to bone marrow stromal cells augments MM cell growth and pr

95 Previously, we demonstrated that bone marrow stromal cell (BMSC) and CB-BF pellet culture

96 ase (CFU-AP(+)), and mineralizing nodules in bone marrow stromal cell (BMSC) cultures.

97 blished a protocol for rat mandible and long-bone marrow stromal cell (BMSC) isolation and culture.

98 l RNA, and using it, we profiled three human bone marrow stromal cell (BMSC) lines.

99 To identify human bone marrow stromal cell (BMSC) subsets with enhanced ab

100 the interaction between multiple myeloma and bone marrow stromal cells (BMSC) and further defined the

101 In vitro studies suggest that bone marrow stromal cells (BMSC) can promote myeloma gro

102 Co-culture of MM cells with patient bone marrow stromal cells (BMSC) showed similar beta1 in

103 NOX2 generates superoxide, which stimulates bone marrow stromal cells (BMSC) to AML blast transfer o

104 morphogenetic protein-2 (BMP-2), seeded with bone marrow stromal cells (BMSC), and maintained in cult

105 In bone marrow stromal cells (BMSC), GJIC and osteogenic di

106 myeloma cells in the presence or absence of bone marrow stromal cells (BMSC), without altering const

107 Administering bone marrow stromal cells (BMSCs -- also known as mesenc

108 t (CRT) is enhanced by the administration of bone marrow stromal cells (BMSCs) after experimental str

109 Cdo1) promoted adipogenesis of primary mouse bone marrow stromal cells (BMSCs) and 3T3-L1 pre-adipocy

110 steoblast progenitors was diminished in both bone marrow stromal cells (BMSCs) and calvarial cells of

111 CDDO-IM also triggers apoptosis in bone marrow stromal cells (BMSCs) and decreases interleu

112 significantly increasing myeloma adhesion to bone marrow stromal cells (BMSCs) and enhancing myeloma

113 secretion of interleukin 6 (IL-6) induced in bone marrow stromal cells (BMSCs) by binding of MM cells

114 Whereas it is now clear that human bone marrow stromal cells (BMSCs) can be immunosuppressi

115 e show the difference in the metabolomics of bone marrow stromal cells (BMSCs) derived from hyperglyc

116 actor 1 (IGF-1), or adherence of MM cells to bone marrow stromal cells (BMSCs) did not protect agains

117 Osteogenic potential of bone marrow stromal cells (BMSCs) differs between MB ver

118 lin-like growth factor-1, or co-culture with bone marrow stromal cells (BMSCs) do not protect against

119 Primary FBLP-1 null bone marrow stromal cells (BMSCs) exhibited significantl

120 hat a local, intrathecal (i.t.) injection of bone marrow stromal cells (BMSCs) following lumbar punct

121 of culture-expanded autologous or allogeneic bone marrow stromal cells (BMSCs) form cortico-cancellou

122 Relative to WT mice, undifferentiated bone marrow stromal cells (BMSCs) from KO mice express h

123 Bone marrow stromal cells (BMSCs) have the potential to

124 ssed on PDGFR-alpha(+), Sca-1(+) multipotent bone marrow stromal cells (BMSCs) in mice, as well as on

125 factor 15 (GDF15) is aberrantly secreted by bone marrow stromal cells (BMSCs) in MM.

126 thesis that the function of implant-adherent bone marrow stromal cells (BMSCs) in osteoclastogenesis

127 ibited growth of MM cells in the presence of bone marrow stromal cells (BMSCs) in vitro.

128 Adherence to bone marrow stromal cells (BMSCs) increased the percenta

129 Adherence of MM cells to bone marrow stromal cells (BMSCs) induced increased Mcl-

130 ed whether MVs can interact and modulate CLL bone marrow stromal cells (BMSCs) known to provide a "ho

131 Recent literature suggests that bone marrow stromal cells (BMSCs) may be differentiated

132 BMP-2-directed osteogenic differentiation of bone marrow stromal cells (BMSCs) of Bag-1(+/-) (heteroz

133 owing intrastriatal transplantation of mouse bone marrow stromal cells (BMSCs) or saline infusion in

134 ) and intrastriatal transplantation of mouse bone marrow stromal cells (BMSCs) or saline infusion in

135 We hypothesized that bone marrow stromal cells (BMSCs) participate in this pr

136 , we developed a mouse MM model in which the bone marrow stromal cells (BMSCs) remained unresponsive

137 pic bone formation in muscle, but can induce bone marrow stromal cells (BMSCs) to form bone in a mous

138 uire either exogenous human IL-6 (huIL-6) or bone marrow stromal cells (BMSCs) to proliferate in vitr

139 Binding of multiple myeloma (MM) cells to bone marrow stromal cells (BMSCs) triggers expression of

140 feration of MM cells induced by adherence to bone marrow stromal cells (BMSCs) was also inhibited by

141 To investigate this question, bone marrow stromal cells (BMSCs) were cultured: in the

142 solation of homogeneous populations of mouse bone marrow stromal cells (BMSCs), a common problem bein

143 Systemic infusion of bone marrow stromal cells (BMSCs), a major type of multi

144 by growth factors and cytokines secreted by bone marrow stromal cells (BMSCs), costimulation with fi

145 ient cells, decreases binding of MM cells to bone marrow stromal cells (BMSCs), inhibits the producti

146 Using human primary bone marrow stromal cells (BMSCs), lymphoblasts, and ski

147 Wnt5a/Ror2 signaling, which can derive from bone marrow stromal cells (BMSCs), takes a role in modul

148 o inhibits viability of MM cells adherent to bone marrow stromal cells (BMSCs), thereby overcoming a

149 ndothelial growth factor (VEGF) secretion in bone marrow stromal cells (BMSCs), without affecting the

150 vitro by disrupting adhesion of MM cells to bone marrow stromal cells (BMSCs).

151 nto chondrogenic nodules of cultured ank/ank bone marrow stromal cells (BMSCs).

152 vival triggered by cytokines and adhesion to bone marrow stromal cells (BMSCs).

153 cytotoxicity against normal lymphocytes and bone marrow stromal cells (BMSCs).

154 ike growth factor-1 (IGF-1), or adherence to bone marrow stromal cells (BMSCs).

155 0125 inhibits growth of MM cells adherent to bone marrow stromal cells (BMSCs).

156 ized for transfection efficiency using human bone marrow stromal cells (BMSCs).

157 ures as compared with those co-cultured with bone marrow stromal cells (BMSCs).

158 ytotoxicity, and capacity to transfect human bone marrow stromal cells (BMSCs).

159 Human bone marrow stromal cells (BMSCs, also known as bone mar

160 It is highly expressed in bone-marrow stromal cells (BMSCs), hepatocytes, and adip

161 Bone marrow stromal cells [BMSCs; also known as mesenchy

162 ion, we conditionally deleted Lepr from limb bone marrow stromal cells, but not from the axial skelet

163 8 promotes commitment and differentiation of bone marrow stromal cells by activating a positive Wnt s

164 rleukin-6, insulin-like growth factor-1, and bone marrow stromal cell coculture.

165 Finally, adherence of MM cells to bone marrow stromal cells confers growth and resistance

166 NGF, which is normally expressed by bone marrow stromal cells, could provide important proli

167 cell-intrinsic and could be recapitulated on bone marrow stromal cell culture.

168 Isolated rat bone marrow stromal cells cultured in osteogenic medium

169 formation, osteoblastogenesis was studied in bone marrow stromal cell cultures obtained from COX-2(-/

170 In vitro bone marrow stromal cell cultures showed there was a sig

171 In bone marrow stromal cell cultures, r-irisin rapidly phos

172 escued decreased mineralization in Fgf2(-/-) bone marrow stromal cell cultures.

173 agonist also stimulated MMP-9 expression in bone marrow stromal cell cultures.

174 Accordingly, we found that bone marrow stromal cell CYP26 was also able to inactiva

175 thane) resulted in a decrease in adhesion to bone marrow stromal cells, cytokine secretion, and in th

176 ough a receptor for A2t has been cloned from bone marrow stromal cells, data contained in this study

177 tion was also inhibited when cocultured with bone marrow stromal cells, demonstrating ability to over

178 activates caspase-3 in pro/pre-B cells in a bone marrow stromal cell-dependent manner, resulting in

179 and phosphorylation of ERK is attenuated in bone marrow stromal cells derived from GPRC6A(-/-) mice

180 ounding occurred after a necessary switch in bone marrow stromal cell-derived factor-1alpha (SDF-1alp

181 n-activated protein kinase (MAPK) in a human bone marrow stromal cell-derived myogenic subclone suppr

182 c effects allow hsp90 inhibitors to abrogate bone marrow stromal cell-derived protection on MM tumor

183 nin was decreased significantly in Fgf2(-/-) bone marrow stromal cells during osteoblast differentiat

184 d with the BST2 cDNA and incubated with HS-5 bone marrow stromal cells, exhibited up to 1.7-fold redu

185 We found that, in vitro, bone marrow stromal cells exposed to IR enter DNA replic

186 ain reaction (RT-PCR) analysis revealed that bone marrow stromal cells express 5 FGF receptors (FGFRs

187 Here, we show that bone marrow stromal cells express endocannabinoids (anan

188 Consistently, bone marrow stromal cells express galectin-3, the recept

189 B cell progenitors and bone marrow stromal cells express Wnt ligands, Frizzled

190 Bone marrow stromal cells from Clec11a-deficient mice sh

191 eficient hematopoietic stem cells (HSCs) and bone marrow stromal cells from human patients with FA.

192 lycan link protein 1 (HAPLN1) is produced in bone marrow stromal cells from MM patients, is detected

193 Moreover, in cocultures of cell lines with bone marrow stromal cells from myeloma patients, the inh

194 Further, bone marrow stromal cells from the mutant mice more read

195 independent and likely results from altered bone marrow stromal cell function.

196 to stimulate their endogenous growth state, bone marrow stromal cell grafts in lesion sites to provi

197 stromal cell line M2-10B4 and human primary bone marrow stromal cells have confirmed that NELL-1 enh

198 n was also observed in the presence of human bone marrow stromal cells (hBMSC), suggesting that our a

199 s show that intravascular injection of human bone marrow stromal cells (hBMSCs) significantly improve

200 Human bone marrow stromal cells (hMSCs) enhance neurological r

201 Adult human bone marrow stromal cells (hMSCs) grown in suspension cu

202 ypothesis that intravenous infusion of human bone marrow stromal cells (hMSCs) promotes vascular endo

203 on significantly enhanced HSPC attachment to bone marrow stromal cells, homing and long-term engraftm

204 hance the proliferative capacity of bone and bone marrow stromal cells; however, the mechanisms behin

205 on (with 1-15 nM IC50), whereas normal human bone marrow stromal cells (HS-27A and HS-5 lines) were r

206 fferentiation by coculture of hPSCs with OP9 bone marrow stromal cells; (ii) short-term expansion of

207 tabolic alterations, we investigated whether bone marrow stromal cells impact the bioenergetics of pr

208 protein inhibit the osteogenic properties of bone marrow stromal cells in coculture assays.

209 human Clec11a promoted osteogenesis by human bone marrow stromal cells in culture and in vivo.

210 at these isolated cells co-cultured with S17 bone marrow stromal cells in cytokine-supplemented mediu

211 We investigated the role of p53 in bone marrow stromal cells in stromal cell-mediated resis

212 teomalacia; however, cultures of Hyp-derived bone marrow stromal cells in the absence of Mepe showed

213 Coculture with bone marrow stromal cells in the presence of supernatant

214 ile coculturing with Notch ligand-expressing bone marrow stromal cells in vitro.

215 activation of STAT3 between tumor cells and bone marrow stromal cells including not only monocytes b

216 ase production and mineralization, in murine bone marrow stromal cells indicating that DKK-1 blocked

217 PC3-bone marrow stromal cell interaction increased secretion

218 ssociated with decreased duration of myeloma/bone marrow stromal cell interaction.

219 n negatively impacted the differentiation of bone marrow stromal cells into osteoblasts and the activ

220 ased TGF-beta signaling in bgn/dcn-deficient bone marrow stromal cells is a "switch in fate" from gro

221 ivator NF-kappaB ligand (RANKL) synthesis by bone marrow stromal cells is a fundamental component of

222 growth of multiple myeloma cells adherent to bone marrow stromal cells is also significantly inhibite

223 y showed that galectin-1 (GAL1), produced by bone marrow stromal cells, is a pre-BCR ligand that indu

224 c cells but no long-term growth on preformed bone marrow stromal cell layers comprised of the AC6.21

225 In vitro studies using the mouse bone marrow stromal cell line M2-10B4 and human primary

226 ed in human embryonal kidney 293 cells and a bone marrow stromal cell line.

227 ation through vascular endothelial cells and bone marrow stromal cell lines.

228 cipitation analysis, we demonstrated that in bone marrow stromal cells, loss of SRC-2 leads to destab

229 Bone marrow stromal cells maintain the adult skeleton by

230 In particular, bone marrow stromal cells may be a frequent target of hu

231 determine if endothelial cells could enhance bone marrow stromal-cell-mediated bone regeneration in a

232 estigate the potential beneficial effects of bone marrow stromal cell (MSC) treatment of traumatic br

233 Bone marrow stromal cells (MSC) are non-hematopoietic su

234 demonstrated that either transplantation of bone marrow stromal cells (MSC) or physical exercise reg

235 scribe our preclinical studies on the use of bone-marrow stromal cells (MSC; an uncharacterised mixed

236 Bone marrow stromal cells (MSCs) are being evaluated as

237 Bone marrow stromal cells (MSCs) have been shown to inhi

238 recently differentiated adult rat and human bone marrow stromal cells (MSCs) into presumptive neuron

239 Control injections of bone marrow stromal cells (MSCs) or fibroblasts 1 mm fro

240 ion of HPF-labeled hematopoietic stem cells, bone marrow stromal cells, neural stem cells or T cells

241 Neither coculture with bone marrow stromal cells nor cytokines (interleukin-6 a

242 ovide evidence that metabolite transfer from bone marrow stromal cells occurs through membrane exchan

243 ional role of ILK activation in leukemic and bone marrow stromal cells on their direct contact.

244 Importantly, bone marrow stromal cells or endothelium deficient in An

245 ortezomib or 17-AAG, even in the presence of bone marrow stromal cells or exogenous IL-6.

246 in vitro without showing toxicity to normal bone marrow stromal cells or hematopoietic progenitor ce

247 Targeted knockdown of Akt2 in mouse primary bone marrow stromal cells or in a mesenchymal stem cell

248 Targeted knockdown of Akt1 in mouse primary bone marrow stromal cells or in a mesenchymal stem cell

249 In contrast, bone marrow stromal cells or interleukin-4 (IL-4) signif

250 sis in MM cells, alone and in coculture with bone marrow stromal cells or various effector cells.

251 Bone marrow stromal cells/osteoblasts were originally th

252 e myeloma cell growth induced by adhesion to bone marrow stromal cells; overcome the growth advantage

253 Our results suggest that CD28 on bone marrow stromal cells participates in stromal-depend

254 Our results indicate that bone marrow stromal cells, precoated on the implant, acc

255 g using SU5402 in Hyp- and Dmp1(-/-)-derived bone marrow stromal cells prevented the increase in Fgf2

256 Although bone marrow stromal cells provide survival signals to my

257 tutive expression of the chemokine CXCL12 by bone marrow stromal cells provides a key retention signa

258 nd other non-Hodgkin lymphoma (NHL) cells to bone marrow stromal cells resulted in a reversible G(1)

259 lying FGF2 inhibition of SDF-1 production in bone marrow stromal cells revealed that FGF2 reduces the

260 During B-cell development, bone marrow stromal cells secreting galectin-1 (GAL1) co

261 pinal cord injury, and we found that grafted bone marrow stromal cells secreting the Wnt inhibitors s

262 endritic cells, hematopoetic stem cells, and bone marrow stromal cells seem resistant to mATG depleti

263 however, we here have prospectively isolated bone marrow stromal cell subsets from both human and mou

264 The lesion site was filled with bone marrow stromal cells, tet-off-NT-3 virus was inject

265 Importantly, bone marrow stromal cells that are deficient for IGFBP2

266 Mesenchymal stem cells (MSCs) are bone marrow stromal cells that are in phase 1 clinical s

267 Importantly, 17f had minimal effects on bone marrow stromal cells that play vital functions in t

268 ve expansion as a result of interaction with bone marrow stromal cells that produce interleukin-6 (IL

269 (2014) describe a signaling axis present in bone marrow stromal cells that suppresses inflammation a

270 In addition, bone marrow stromal cells that were either deficient in

271 production of the growth factor, IL-6, from bone marrow stromal cells, that is stimulated by adhesio

272 s were generated by attaching cultured human bone marrow stromal cells to aliquots of HA-TCP particle

273 , TG mice showed enhanced differentiation of bone marrow stromal cells to osteoblasts and increased e

274 rather that plasma cells contact and modify bone marrow stromal cells to provide survival factors.

275 , but only NICD suppressed the commitment of bone marrow stromal cells to the osteoblastic lineage.

276 ignificantly, adoptive transfer of wild-type bone-marrow stromal cells to TLR3-/- mice abolished the

277 verts dividing osteoblastic precursor cells (bone marrow stromal cells) to a metabolically stressed a

278 d human leukemia cells--cultured alone or on bone marrow stromal cells--to apoptosis induction by ABT

279 o-cell contact between myeloma cells and the bone marrow stromal cells triggers a large amount of int

280 After long-term coculture with bone marrow stromal cells, tumor cells formed hematopoie

281 Multiple bone marrow stromal cell types have been identified as h

282 to an osteoblast defect, because MAGP1Delta bone marrow stromal cells undergo osteoblastogenesis and

283 B cell line, primary pro-B cells cultured on bone marrow stromal cells underwent apoptosis after expo

284 tion of osteoclastogenesis by Cx43-deficient bone marrow stromal cells, via decreased Opg production.

285 adhesion of CD117-expressing blast cells to bone-marrow stromal cells was significantly inhibited by

286 Here, using as a model bone marrow stromal cells, we describe a novel signaling

287 n in stimulating interleukin-6 expression in bone marrow stromal cells, we observed that recombinant

288 g coculture of human ES (hES) cells with OP9 bone marrow stromal cells, we were able to obtain up to

289 However, when adherent bone marrow stromal cells were allowed to mature into al

290 study MG63 osteoblast-like cells and primary bone marrow stromal cells were both shown to produce OPG

291 dorsal column sensory axons, and autologous bone marrow stromal cells were grafted into the lesion t

292 Rat bone marrow stromal cells were seeded in 3D porous titan

293 d in interactions between leukemia cells and bone marrow stromal cells, were 7.3-fold higher (validat

294 ed endothelialized channels lined with human bone marrow stromal cells, which adopt a mural cell-like

295 y mouse embryonic fibroblasts, primary mouse bone marrow stromal cells, whole mouse bone marrow and i

296 122(-))NK1.1(-) thymocytes on irradiated OP9 bone marrow stromal cells with IL-15, IL-7, Flt3L, and s

297 bone tumors, and in vitro in co-cultures of bone marrow stromal cells with PC3 prostate carcinoma ce

298 d processing of SPARC, as did co-cultures of bone marrow stromal cells with two other cancer cell lin

299 h ligand Delta-like 1 (DL1) overexpressed on bone marrow stromal cells, with complete maturation occu

300 n of adhesion molecules on both MM cells and bone marrow stromal cells, with resultant increased adhe